Minocycline slow-release formulation effect on subgingival bacteria.
The purpose of this study was to determine the microbiological efficacy of an adjunctive minocycline periodontal formulation delivered subgingivally. Subjects were systemically healthy but exhibited severe periodontitis; i.e., probing depths greater than 6 mm. The two study groups included individuals who received minocycline or a placebo periodontal formulation after root planing. Subgingival plaque samples were obtained at baseline; prior to treatment; and at 1, 3, and 6 months. Plaque was evaluated by darkfield microscopy and further analyzed for total dark-pigmented Bacteroides species, P. intermedia, P. gingivalis and Streptococcus, Actinomyces, Eikenella, Actinobacillus, Capnocytophaga, and Fusobacterium species using cultivable flora techniques. In addition, plaque was evaluated for yeast on a selective agar medium. When compared to the placebo, the minocycline group had significantly lower proportions of spirochetes at 1 and 3 months and lower proportions of motile rods at 3 months. Furthermore, when compared to the placebo group, the minocycline patients had lower mean proportions of dark-pigmented Bacteroides spp. and P. intermedia at 1 and 3 months as well as lower proportions of E. corrodens at 1 month. The minocycline group had significant decreases in proportions of spirochetes at 1 and 3 months, motile rods at 1 and 3 months, and increases in cocci at 1, 3, and 6 months when compared to baseline. In the placebo group, root planing was also effective at decreasing spirochetes at 1, 3, and 6 months, but with significant differences seen only at 3 and 6 months. However, the degree of reduction in spirochete proportions was greater in the minocycline group when compared with the placebo group.(ABSTRACT TRUNCATED AT 250 WORDS)
Okuda
K
K
Department of Periodontology, Niigata University, School of Dentistry, Japan.
Wolff
L
L
Oliver
R
R
Osborn
J
J
Stoltenberg
J
J
Bereuter
J
J
Anderson
L
L
Foster
P
P
Hardie
N
N
Aeppli
D
D
D000190:Actinomyces / Q000187:drug effects / Q000302:isolation & purification; D000328:Adult; D000368:Aged; D001419:Bacteria / Q000187:drug effects / Q000302:isolation & purification*; D001439:Bacteroides / Q000187:drug effects / Q000302:isolation & purification; D015169:Colony Count, Microbial; D003692:Delayed-Action Preparations; D003773:Dental Plaque / Q000382:microbiology; D012534:Dental Scaling; D004343:Drug Implants; D005260:Female; D005881:Gingiva; D006801:Humans; D008297:Male; D008875:Middle Aged; D008911:Minocycline / Q000008:administration & dosage / Q000627:therapeutic use*; D010514:Periodontal Pocket / Q000188:drug therapy* / Q000382:microbiology*; D010919:Placebos; D016745:Root Planing; D013144:Spirochaetales / Q000187:drug effects / Q000302:isolation & purification
D003692:Delayed-Action Preparations; D004343:Drug Implants; D010919:Placebos; D008911:Minocycline